An End-user Perspective on Laboratory Spending Reveals Modest 2021 Budget Increases Following Healthier 2020 Spending
26-Mar-2021
North America
Customer Research
K5C1-01-00-00-00
HC03403-NA-CR_25330
Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey in September 2020 that centered on the state of their laboratories in 2020 and their expectations for 2021. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. Where applicable, the study presents year-over-year data to illustrate yearly trend developments. To qualify for survey participation, readers had to play a role in their laboratory’s purchasing process, be familiar with their laboratory’s product budgets, and represent a laboratory that either uses or plans to use products in one or more of the seven specified laboratory product categories: instruments, equipment, chemicals, reagents and kits, general lab supplies, plasticware, and glassware. A total of 211 decision makers qualified for and completed the survey, answering questions on purchases, budgets, top companies, and purchasing preferences. Respondents were segmented by type of laboratory: academic/government, biopharmaceutical, industrial, and clinical.
This end-user survey polled researchers on their preferences in order to understand the laboratory product purchasing process and how that differs among the various organization types. The data collected was quantitative in respect to budgets and qualitative with reference to end-user trends such as budget expectations, brand selection preferences, purchasing process steps, evaluation and sourcing of lab products, recent and expected instrument and equipment purchases, frequency of price comparisons, funding trends, unmet needs, product purchasing preferences, and the impact of COVID-19 on lab shutdowns and spending. This survey provides companies with actionable and trending information from laboratory professionals that will help drive business strategies and develop growth expectations.
For the purpose of this analysis, respondents identifying as manufacturing, environmental testing, chemical or petrochemical, and food, beverage, or agricultural are combined as industrial laboratories. Biotechnology, pharmaceutical, and contract research organization are combined as biopharmaceutical laboratories. State government and federal government laboratories are combined as government laboratories. Hospital laboratories and clinical reference laboratories fall under the clinical segment. Respondents indicated a wide range of job titles including researcher, scientist, investigator, director, manager, and technician.
Author: Christi Bird Ulan
Research Objectives
Research Methodology
Respondent Profile
Respondent Profile (continued)
Key Findings
Budget Changes
Laboratory Product Budget Breakdown and Trend
Laboratory Product Budget Breakdown and Trend (continued)
COVID-19 Impact on Laboratories
COVID-19 Impact on Laboratories (continued)
Growth Opportunity Areas
Annual Comparison of Lab Product Information Sources
Most Frequently sed Information ources
Lab Product Purchases
Annual Comparison of Product Purchases
Lab Product Purchases by Organization Type
Annual Comparison of Experience with Lab Product Purchases
Product Features
Product Features (continued)
Product Origin
Manufacturer Features
Ordering and Shipment Features
Comparing Market Prices
Purchase Channels
Most Frequently Used Purchase Channels
Purchasing Experience Aspects
Laboratory Product Purchase Improvement Areas
Purchasing Experience Aspect Assessment
Purchasing Experience Aspect ssessment (continued)
Purchasing Experience ssessment (continued)
Purchasing Experience Opportunity Areas
Purchasing Experience Opportunity Areas (continued)
Purchasing Experience Opportunity Areas (continued)
2020 Laboratory Product Budget
2020 Laboratory Product Budget (continued)
Laboratory Budget Breakdown and Trend
2020 Laboratory Product Budget Breakdown and 2021 Trend
Laboratory Product Funding Sources
Laboratory Product Funding Sources (continued)
Laboratory Product Funding Source Changes
COVID-19 Impact on Laboratories
COVID-19 Impact on Laboratories (continued)
Laboratory Operating Status
Laboratory Shutdown
COVID-19 Impact on Q4 Spending
List of Exhibits
List of Exhibits (continued)
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Customer Research |
|---|---|
| No Index | No |
| Podcast | No |
| Predecessor | 9AB9-C1 |
| Author | Christi Bird |
| Industries | Healthcare |
| WIP Number | K5C1-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9562-B1,9573-B1,99C6-B1,9627-B1 |
Global Laboratory Product Purchasing Trends, 2020–2021
$4,950.00
Special Price $3,712.50 save 25 %